metformin has been researched along with Acquired Laryngeal Stenosis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"In this investigation, we compared iLTS scar-derived fibroblasts in patients with and without T2DM." | 1.62 | Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus. ( Davis, R; Ding, D; Hillel, AT; Lina, I; Motz, KM; Tsai, HW, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lina, I | 1 |
Tsai, HW | 1 |
Ding, D | 1 |
Davis, R | 1 |
Motz, KM | 1 |
Hillel, AT | 1 |
1 other study available for metformin and Acquired Laryngeal Stenosis
Article | Year |
---|---|
Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus.
Topics: Adult; Aged; Amobarbital; Biopsy; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cicatri | 2021 |